Skip to main content

Table 2 Factors associated with of delayed ART initiation among PLHIV referred for ART at Mulago ISS clinic in the test and treat era

From: Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study

Variable

Category

n = 48 (%)

cOR (95% CI)

P-value

aOR (95% CI)

P-value

Age group

15–24

4 (8.3)

1.0

   

25–34

22 (45.8)

0.8 (0.3–2.5)

0.730

  

> = 35

22 (45.8)

1.3 (0.3–5.4)

0.765

  

Sex

Female

30 (62.5)

1.0

   

Male

18 (37.5)

1.0 (0.5–1.9)

0.960

  

Highest level of Education

None/primary

21 (43.8)

1.0

 

1.0

 

Secondary

17 (35.4)

1.0 (0.5–1.9)

0.906

0.9 (0.4–2.0)

0.771

Tertiary

10 (20.8)

2.2 (0.9–5.1)

0.075

2.4 (0.8–7.1)

0.116

Employment status

Not employed

4 (8.3)

1.0

   

Self employed

27 (56.3)

2.4 (0.8–7.3)

0.114

  

Formal employment

17 (35.4)

2.8 (0.9–8.9)

0.075

  

Marital status

Single

26 (54.2)

1.0

   

Married

22 (45.8)

1.0 (0.6–1.9)

0.884

  

SES

Poorest

17 (35.4)

1.0

 

1.0

 

Poor

6 (12.5)

0.5 (0.2–1.5)

0.230

0.4 (0.1–1.5)

0.173

Medium

5 (10.4)

0.4 (0.1–1.3)

0.122

0.4 (0.1–1.2)

0.101

Wealthy

14 (29.2)

0.6 (0.3–1.3)

0.202

0.5 (0.2–1.3)

0.150

Wealthiest

6 (12.5)

1.0 2.7 (0.8–8.6)

0.093

2.5 (0.6–10.5)

0.211

Place of HIV diagnosis

Public facility

17 (35.4)

1.0

 

1.0

 

Private facility

25 (52.1)

3.1 (1.6–6.1)

0.001

2.4 (1.1–5.5)

0.037

Outreach

6 (12.5)

2.4 (0.8–7.3)

0.114

2.9 (0.8–10.4)

0.096

Counselling during HIV diagnosis

Both pre and post testing

28 (58.3)

1.0

 

1.0

 

Either pre or post testing

10 (20.8)

2 (0.9–4.4)

0.086

1.0 (0.4–2.5)

0.933

None

10 (20.8)

5 (2.1–12.3)

< 0.001

1.3 (0.4–4.3)

0.710

Accepted HIV positive results

Yes

33 (68.8)

1.0

 

1.0

 

No

15 (31.3)

8.1 (3.6–18.3)

< 0.001

5.4 (2.0–15.0)

0.001

Received a referral note to higher health facility

Yes

24 (50.0)

1.0

 

1.0

 

No

24 (50.0)

5.3 (2.7–10.2)

< 0.001

1.7 (0.7–4.5)

0.244

Received a follow-up phone call after referral from place of testing.

Yes

15 (31.3)

1.0

 

1.0

 

No

33 (68.8)

4.3 (2.2–8.2)

< 0.001

2.8 (1.2–6.8)

0.019

Baseline CD4 count before ART initiation.

< 200 cells/μL

13 (27.1)

1.0

 

1.0

 

≥200 cells/μL

35 (72.9)

1.4 (0.7–2.8)

0.320

1.3 (0.6–2.9)

0.515

HIV associated comorbidities

None

44 (91.7)

1.0

   

Tuberculosis

1 (2.1)

0.2 (0.03–1.5)

0.116

  

Cryptococcal Meningitis

3 (6.3)

8.0 (1.3–49.3)

0.025

  
  1. n Number that delayed ART initiation, cOR Crude Odds Ratio, aOR Adjusted Odds Ratio, SES Social economic status
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us